What are the possible causes of absent bilateral semimembranosus muscle in an adult female?

Bilateral Absence of Semimembranosus Muscle in Adult Female

Bilateral absence of the semimembranosus muscle in an adult female is most likely a congenital anatomical variant, though acquired causes including muscular dystrophy, inflammatory myopathies, and severe muscle atrophy from chronic disease must be systematically excluded.

Primary Differential Diagnosis

1. Congenital Absence (Most Likely)

• Isolated congenital absence is a rare but well-documented anatomical variant 1, 2
• Typically discovered incidentally on imaging (MRI) performed for unrelated complaints
• May be associated with atypical morphologies of adjacent hamstring muscles (semitendinosus, biceps femoris) 1
• Usually asymptomatic with preserved function due to compensation by remaining hamstring muscles
• Key feature: No history of progressive weakness, normal muscle enzymes, stable throughout life

2. Muscular Dystrophy

Limb-girdle muscular dystrophy (LGMD), particularly dysferlinopathies, presents in adult years with proximal muscle involvement 3

• Look for: Progressive proximal weakness, elevated creatine kinase (often markedly elevated), family history
• Calpain and dysferlin disease: Significant cardiac involvement is infrequent 4
• Sarcoglycan disease: Very common cardiac involvement 4
• Muscle biopsy shows: Reduction/absence of specific proteins, degenerating/regenerating fibers, replacement with fat or connective tissue 3
• Genetic testing confirms specific dystrophin gene mutations 3

3. Inflammatory Myopathies

Polymyositis (PM) or immune-mediated necrotizing myopathy (IMNM) can cause severe muscle loss 3

• Look for: Symmetric proximal weakness, elevated muscle enzymes (CK, aldolase), acute or subacute onset
• IMNM: Severe myopathy with minimal inflammatory infiltrate, may be triggered by statins 3
• Anti-SRP antibody: Necrotizing myopathy, acute onset, dilated cardiomyopathy, poor response to immunosuppression 3
• EMG shows myopathic pattern; muscle biopsy is gold standard 3

4. Endocrine/Metabolic Myopathy

Thyroid disorders or hyperparathyroidism can cause chronic muscle atrophy 3

• Look for: Systemic signs of endocrine dysfunction, elevated muscle enzymes
• Thyroid function tests and parathyroid hormone levels are diagnostic
• Muscle changes are typically reversible with treatment

5. Drug-Induced Myopathy

Statin-induced myopathy can progress to severe muscle damage 3

• Look for: History of statin use, elevated CK, may progress to IMNM
• Discontinuation of offending agent is critical

6. Mitochondrial Myopathy

Rare but presents with proximal muscle weakness 3

• Look for: Exercise intolerance, multisystem involvement, maternal inheritance pattern
• Muscle biopsy shows "ragged red fibers" on Gomori trichrome stain 3

7. Severe Disuse Atrophy

Chronic immobilization or neurological conditions causing prolonged disuse

• Look for: History of prolonged bed rest, neurological disease, or joint pathology limiting mobility
• Bilateral symmetric pattern would be unusual unless systemic cause

Diagnostic Algorithm

Step 1: Clinical History

• Onset: Lifelong asymptomatic vs. progressive weakness
• Functional status: Normal activity vs. difficulty with stairs, rising from chair
• Medication history: Statins, other myotoxic drugs
• Family history: Muscular dystrophy, autoimmune disease
• Systemic symptoms: Rash, fever, weight loss, endocrine symptoms

Step 2: Physical Examination

• Proximal muscle strength testing (hip flexion, knee extension)
• Gowers' sign (difficulty rising from floor)
• Skin examination for dermatomyositis rashes
• Cardiac examination for cardiomyopathy signs

Step 3: Laboratory Testing

• Creatine kinase: Markedly elevated (>10x normal) suggests dystrophy or inflammatory myopathy; normal suggests congenital absence
• Complete metabolic panel including liver enzymes (AST/ALT are also muscle enzymes)
• Thyroid function tests, parathyroid hormone
• Myositis-specific antibodies if inflammatory myopathy suspected (anti-Jo-1, anti-SRP, anti-Mi2) 3

Step 4: Imaging

• MRI of bilateral thighs: Assess for muscle edema (active inflammation), fatty replacement (chronic disease), or simple absence with normal adjacent muscles 3
• T2-weighted sequences show muscle edema in active myositis 3
• T1-weighted shows muscle atrophy and chronic damage 3

Step 5: Electrodiagnostic Testing

• EMG: Myopathic pattern (polyphasic motor units, short duration, low amplitude) confirms muscle disease vs. neurogenic cause 3

Step 6: Muscle Biopsy (if indicated)

• Gold standard for distinguishing inflammatory from noninflammatory myopathy 3
• Choose weak muscle on opposite side from EMG-tested muscle 3
• Immunocytochemistry and immunoblotting for dystrophin in suspected dystrophy 3

Step 7: Genetic Testing

• If dystrophy suspected: Dystrophin gene, dysferlin, calpain, sarcoglycan genes 3

Clinical Pitfalls

• Do not assume congenital absence without excluding acquired causes, especially if any weakness or elevated CK is present
• Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) elevations may be mistaken for liver disease when actually reflecting muscle damage 5
• Normal muscle examination does not exclude early muscular dystrophy in younger patients 5
• Bilateral symmetric absence is extremely rare for congenital variants—most reported cases are unilateral 2, 6
• Stretched scars from previous surgery can mimic muscle absence on imaging 7

Most Likely Diagnosis

If the patient is asymptomatic with normal strength, normal CK, and incidental imaging finding: congenital bilateral absence is the diagnosis 1, 2. This requires no treatment and has no functional implications due to compensation by remaining hamstrings.

If any weakness, elevated enzymes, or progressive symptoms exist: pursue full workup for acquired myopathy as outlined above, prioritizing muscular dystrophy and inflammatory myopathies 3.